NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 126 transactions totaling $973.8K, demonstrating a bearish sentiment with -$563.6K in net insider flow. The most recent transaction on Feb 18, 2026 involved a transaction of 71,325 shares valued at $48.5K.
No significant insider buying has been recorded for NMTC in the recent period.
No significant insider selling has been recorded for NMTC in the recent period.
Based on recent SEC filings, insider sentiment for NMTC is bearish with an Insider Alignment Score of 21/100 and a net flow of -$563.6K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading NMTC stock, having executed 126 transactions in the past 90 days. The most active insider is Foundation For Medical Education &. Research Mayo (Executive), who has made 1 transactions totaling $1.2M.
Get notified when executives and directors at NMTC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | A. Rosa David | Executive | Payment | 71,325 | $0.68 | $48.5K | |
| Feb 18, 2026 | Christianson Mark | Business Development Director | Payment | 1,812 | $0.68 | $1.2K | C-Suite |
| Feb 18, 2026 | Mertens Steve | Chief Technology Officer | Payment | 7,376 | $0.68 | $5.0K | C-Suite |
| Dec 31, 2025 | Mertens Steve | Chief Technology Officer | Payment | 906 | $0.76 | $687 | C-Suite |
| Sep 30, 2025 | A. Rosa David | Executive | Payment | 2,458 | $0.89 | $2.2K | |
| Sep 30, 2025 | Christianson Mark | Executive | Payment | 253 | $0.89 | $225 | |
| Sep 30, 2025 | Mertens Steve | Executive | Payment | 906 | $0.89 | $806 | |
| Sep 5, 2025 | Christianson Mark | Executive | Sale | 30,000 | $0.74 | $22.2K | |
| Jun 30, 2025 | A. Rosa David | Executive | Payment | 2,458 | $0.68 | $1.7K | |
| Jun 30, 2025 | Mertens Steve | Executive | Payment | 906 | $0.68 | $616 | |
| Jun 30, 2025 | Christianson Mark | Executive | Payment | 253 | $0.68 | $172 | |
| Aug 31, 2024 | A. Rosa David | Executive | Payment | 2,239 | $0.80 | $1.8K | |
| Aug 31, 2024 | Christianson Mark | Executive | Payment | 90 | $0.80 | $72 | |
| Aug 31, 2024 | Mertens Steve | Executive | Payment | 252 | $0.80 | $202 | |
| Aug 1, 2024 | Buckman Paul | Executive | Award | 27,778 | $0.81 | $22.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 2 | $1.7M | 58.2% |
Sale(S) | 16 | $768.7K | 26.0% |
Payment(F) | 70 | $240.1K | 8.1% |
Purchase(P) | 6 | $205.1K | 6.9% |
Award(A) | 31 | $22.5K | 0.8% |
Exercise(M) | 1 | $1.4K | 0.0% |
Insider selling pressure at NEUROONE MEDICAL TECHNOLOGIES Corp has increased, with 11 insiders executing 126 transactions across all time. Total sales of $768.7K significantly outpace purchases of $205.1K, resulting in a net outflow of $563.6K. This selling activity appears largely discretionary, which may warrant closer attention from investors.